(-)-2-beta-Carbomethoxy-3-beta- (4-iodophenyl)tropane (10 mg)
                            
                        
                            
                                Precursor for [*I]beta-CIT
Reference standard for [*I]beta-CIT
                            
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                        
                            
                                
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane
Product No.:CIT-97 
 CAS No.:135416-43-2
|  |  | 
| Product Name: | 
| (-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane |  | 
| Synonyms: | 
| 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(4-iodophenyl)-8-methyl, methyl ester, (1R,2S,3S,5S)-; beta-CIT; 2-CIT |  | 
| CAS No.: |  | 
| Molecular Formula: |  | 
| Molecular Weight: |  | 
| Application: | 
| Precursor for [*I]beta-CIT |  | 
| Presentation: | Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere. | 
Note
- Care must be taken when handling this product.
- Do not contact skin or eyes.
- Do not ingest or inhale.
- Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
- It shall be only used by qualified personnel.
Order Number
- CIT-97-0010x       10mg per vial 
- CIT-97-0020x       20mg per vial
- note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial 
- *Customized dispensing is available
 
Literature
- Goodman M.M. et al. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters. J. Nucl. Med. 1997, 38,119–126.
- Chitneni S.K. et al. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [18F]FECT. Nucl. Med. Biol. 2008, 35, 75–82.